Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening

BACKGROUND: In 2016, it is estimated that there will be 62,700 new cases of kidney cancer in the United States, and 14,240 patients will die from the disease. Because the incidence of kidney renal clear cell carcinoma (KIRC), the most common type of kidney cancer, is expected to continue to increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Guangchun, Zhao, Wei, Song, Xiaofeng, Kwok-Shing Ng, Patrick, Karam, Jose A., Jonasch, Eric, Mills, Gordon B., Zhao, Zhongming, Ding, Zhiyong, Jia, Peilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629613/
https://www.ncbi.nlm.nih.gov/pubmed/28984208
http://dx.doi.org/10.1186/s12864-017-4026-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629613/
https://www.ncbi.nlm.nih.gov/pubmed/28984208
http://dx.doi.org/10.1186/s12864-017-4026-6

Ejemplares similares